202 related articles for article (PubMed ID: 29295842)
1. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice.
Girard-Guyonvarc'h C; Palomo J; Martin P; Rodriguez E; Troccaz S; Palmer G; Gabay C
Blood; 2018 Mar; 131(13):1430-1441. PubMed ID: 29295842
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.
Weiss ES; Girard-Guyonvarc'h C; Holzinger D; de Jesus AA; Tariq Z; Picarsic J; Schiffrin EJ; Foell D; Grom AA; Ammann S; Ehl S; Hoshino T; Goldbach-Mansky R; Gabay C; Canna SW
Blood; 2018 Mar; 131(13):1442-1455. PubMed ID: 29326099
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.
Canna SW; Wrobel J; Chu N; Kreiger PA; Paessler M; Behrens EM
Arthritis Rheum; 2013 Jul; 65(7):1764-75. PubMed ID: 23553372
[TBL] [Abstract][Full Text] [Related]
4. Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome.
Harel M; Girard-Guyonvarc'h C; Rodriguez E; Palmer G; Gabay C
J Immunol; 2020 Aug; 205(4):1167-1175. PubMed ID: 32651219
[TBL] [Abstract][Full Text] [Related]
5. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
[TBL] [Abstract][Full Text] [Related]
6. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.
Behrens EM; Canna SW; Slade K; Rao S; Kreiger PA; Paessler M; Kambayashi T; Koretzky GA
J Clin Invest; 2011 Jun; 121(6):2264-77. PubMed ID: 21576823
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.
Prencipe G; Caiello I; Pascarella A; Grom AA; Bracaglia C; Chatel L; Ferlin WG; Marasco E; Strippoli R; de Min C; De Benedetti F
J Allergy Clin Immunol; 2018 Apr; 141(4):1439-1449. PubMed ID: 28807602
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome.
Weaver LK; Chu N; Behrens EM
Arthritis Rheumatol; 2019 Jan; 71(1):161-168. PubMed ID: 30073799
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance.
Verweyen E; Holzinger D; Weinhage T; Hinze C; Wittkowski H; Pickkers P; Albeituni S; Verbist K; Nichols KE; Schulert G; Grom A; Foell D; Kessel C
Am J Respir Crit Care Med; 2020 Mar; 201(5):526-539. PubMed ID: 31710506
[No Abstract] [Full Text] [Related]
10. Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein.
Millward JM; Løbner M; Wheeler RD; Owens T
J Immunol; 2010 Aug; 185(4):2458-66. PubMed ID: 20644165
[TBL] [Abstract][Full Text] [Related]
11. IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome.
Harel M; Fauteux-Daniel S; Rodriguez E; Palmer G; Gabay C
J Immunol; 2023 Jun; 210(11):1790-1803. PubMed ID: 37074208
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18, more than a Th1 cytokine.
Novick D; Kim S; Kaplanski G; Dinarello CA
Semin Immunol; 2013 Dec; 25(6):439-48. PubMed ID: 24275602
[TBL] [Abstract][Full Text] [Related]
13. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of experimental asthma by mycobacterial protein combined with CpG requires a TLR9-dependent IFN-γ-CCR2 signalling circuit.
Prado RQ; Bertolini TB; Piñeros AR; Gembre AF; Ramos SG; Silva CL; Borges MC; Bonato VL
Clin Exp Allergy; 2015 Sep; 45(9):1459-71. PubMed ID: 25944185
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome.
Gao DK; Salomonis N; Henderlight M; Woods C; Thakkar K; Grom AA; Thornton S; Jordan MB; Wikenheiser-Brokamp KA; Schulert GS
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314387
[TBL] [Abstract][Full Text] [Related]
16. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of Murine Macrophage Activation Syndrome by Monomethyl Fumarate in Both a Heme Oxygenase 1-Dependent and Heme Oxygenase 1-Independent Manner.
Biswas C; Chu N; Burn TN; Kreiger PA; Behrens EM
Arthritis Rheumatol; 2021 May; 73(5):885-895. PubMed ID: 33191652
[TBL] [Abstract][Full Text] [Related]
18. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
19. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
[TBL] [Abstract][Full Text] [Related]
20. A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.
Li S; Jiang L; Beckmann K; Højen JF; Pessara U; Powers NE; de Graaf DM; Azam T; Lindenberger J; Eisenmesser EZ; Fischer S; Dinarello CA
J Biol Chem; 2021; 296():100630. PubMed ID: 33823154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
